Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Boyer

Showing results (171-180 of 194) with videos related to

Pageof 20
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 26, 2007
Synthesis and SAR of novel conformationally-restricted oxazolidinones possessing gram-positive and fastidious gram-negative antibacterial activity. Part 1: Substituted pyrazolesFrederick E Boyer, J V N Vara Prasad, Allison L Choy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2022
Survival of Patient With Hemorrhagic Meningitis Associated With Inhalation AnthraxEvelyn Lombarte Espinosa, María Cruz Villuendas Usón, Jorge Arribas García, et al.
Proceedings. Biological Sciences|February 11, 2025
Host traits and temperature predict biogeographical variation in seagrass disease prevalenceF R Schenck, J K Baum, K E Boyer, et al.
The Journal of Infectious Diseases|July 23, 2020
Clindamycin Protects Nonhuman Primates Against Inhalational Anthrax But Does Not Enhance Reduction of Circulating Toxin Levels When Combined With CiprofloxacinNicholas J Vietri, Steven A Tobery, Donald J Chabot, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 1999
Nonpeptidic HIV protease inhibitors: 6-alkyl-5,6-dihydropyran-2-ones possessing a novel and achiral 3-(2-t-butyl-5-methyl-4-sulfamate)phenylthio moietyJ V Vara Prasad, L J Markoski, F E Boyer, et al.
The Journal of Infectious Diseases|September 13, 2011
Lethal factor toxemia and anti-protective antigen antibody activity in naturally acquired cutaneous anthraxAnne E Boyer, Conrad P Quinn, Cari A Beesley, et al.
Journal of Medicinal Chemistry|November 26, 1997
Synthesis of 5,6-dihydro-4-hydroxy-2-pyrones as HIV-1 protease inhibitors: the profound effect of polarity on antiviral activityS E Hagen, J V Prasad, F E Boyer, et al.
Ecology|February 25, 2021
Joint effects of patch edges and habitat degradation on faunal predation risk in a widespread marine foundation speciesKevin A Hovel, J Emmett Duffy, John J Stachowicz, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 1999
Nonpeptidic HIV protease inhibitors: 6-alkyl-5,6-dihydropyran-2-ones possessing achiral 3-(4-amino/carboxamide-2-t-butyl,5-methylphenyl thio) moiety: antiviral activities and pharmacokinetic propertiesJ V Vara Prasad, F E Boyer, J M Domagala, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2007
A case of naturally acquired inhalation anthrax: clinical care and analyses of anti-protective antigen immunoglobulin G and lethal factorJames J Walsh, Nicki Pesik, Conrad P Quinn, et al.
Pageof 20

Showing results (171-180 of 194) with videos related to

Sort By:
Pageof 20
Bioorganic & Medicinal Chemistry Letters|June 26, 2007
Synthesis and SAR of novel conformationally-restricted oxazolidinones possessing gram-positive and fastidious gram-negative antibacterial activity. Part 1: Substituted pyrazolesFrederick E Boyer, J V N Vara Prasad, Allison L Choy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2022
Survival of Patient With Hemorrhagic Meningitis Associated With Inhalation AnthraxEvelyn Lombarte Espinosa, María Cruz Villuendas Usón, Jorge Arribas García, et al.
Proceedings. Biological Sciences|February 11, 2025
Host traits and temperature predict biogeographical variation in seagrass disease prevalenceF R Schenck, J K Baum, K E Boyer, et al.
The Journal of Infectious Diseases|July 23, 2020
Clindamycin Protects Nonhuman Primates Against Inhalational Anthrax But Does Not Enhance Reduction of Circulating Toxin Levels When Combined With CiprofloxacinNicholas J Vietri, Steven A Tobery, Donald J Chabot, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 1999
Nonpeptidic HIV protease inhibitors: 6-alkyl-5,6-dihydropyran-2-ones possessing a novel and achiral 3-(2-t-butyl-5-methyl-4-sulfamate)phenylthio moietyJ V Vara Prasad, L J Markoski, F E Boyer, et al.
The Journal of Infectious Diseases|September 13, 2011
Lethal factor toxemia and anti-protective antigen antibody activity in naturally acquired cutaneous anthraxAnne E Boyer, Conrad P Quinn, Cari A Beesley, et al.
Journal of Medicinal Chemistry|November 26, 1997
Synthesis of 5,6-dihydro-4-hydroxy-2-pyrones as HIV-1 protease inhibitors: the profound effect of polarity on antiviral activityS E Hagen, J V Prasad, F E Boyer, et al.
Ecology|February 25, 2021
Joint effects of patch edges and habitat degradation on faunal predation risk in a widespread marine foundation speciesKevin A Hovel, J Emmett Duffy, John J Stachowicz, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 1999
Nonpeptidic HIV protease inhibitors: 6-alkyl-5,6-dihydropyran-2-ones possessing achiral 3-(4-amino/carboxamide-2-t-butyl,5-methylphenyl thio) moiety: antiviral activities and pharmacokinetic propertiesJ V Vara Prasad, F E Boyer, J M Domagala, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2007
A case of naturally acquired inhalation anthrax: clinical care and analyses of anti-protective antigen immunoglobulin G and lethal factorJames J Walsh, Nicki Pesik, Conrad P Quinn, et al.
Pageof 20